Referral pathways and physician understanding lag the science — and KOL mapping is fragmented across six languages. Theranostix helps you identify the right clinicians and centres and engage them through independent, multilingual education.
Radioligand therapy depends on referrers and treaters who understand it and trust the pathway. Yet medical teams lack a clear, EU-wide view of who the active voices and centres are — and engaging them across languages and markets is slow and uneven.
Active contributors, authors and treating centres are scattered across countries and languages, with no single map.
Where referral pathways are undefined, eligible patients never reach a treating centre.
Reaching clinicians consistently, in their language and compliantly, is hard to do at scale.
Identify active contributors, case authors and treating centres using aggregated, anonymised signals.
Reach clinicians through dossiers, webinars and content in six languages — sponsorship always labelled.
Support awareness and pathway-building between referrers and treating centres, independently.
Not sure which tier fits? We’ll scope it with you.
Contact salesA 30-minute walkthrough, tailored to you — or talk to sales about a license.
Book an intelligence walkthroughContact sales